ArticleIntractable & rare diseases research2026
Cutaneous lymphomas reported following the use of dupilumab, nemolizumab, tralokinumab, or lebrikizumab: A case investigation based on JADER database and disproportionality analysis.
Hiroyuki Tanaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.